A federal court has begun the claims process for a proposed settlement under which 3M could pay as much as $7.35 billion over nine years to resolve personal-injury claims tied to PFAS in firefighting foam. PFAS, or per- and polyfluoroalkyl substances, are a group of chemicals often called “forever chemicals” because they can persist in the environment.
U.S. District Judge Richard M. Gergel entered an order on Nov. 4, 2026, starting the process for identifying people who may qualify. The litigation is being handled as multidistrict litigation, or MDL, in federal court in South Carolina. An MDL combines similar cases in one court for coordinated proceedings, while preserving individual claims.
Who the agreement covers
The agreement is expected to address about 99% of personal-injury claims against 3M, including cases inside and outside the federal MDL, according to the settlement terms reported by Law360. Approximately 115,000 to 120,000 plaintiffs may be eligible for compensation.
People covered by the agreement must allege that PFAS exposure caused one of six listed conditions. Exposure may have occurred through contaminated drinking water or through direct contact with firefighting foam. The conditions named in the settlement are:
- Kidney cancer
- Testicular cancer
- Liver cancer
- Thyroid cancer
- Ulcerative colitis
- Thyroid disease
The agreement excludes people whose claims were dismissed with prejudice before Nov. 3. A dismissal with prejudice generally prevents the same claim from being brought again. The settlement terms also require participating claimants to release their claims, dismiss their cases with prejudice and give up potential punitive damages, which are damages intended to punish especially wrongful conduct rather than compensate for an injury.
How payments would be calculated
Payments would not be identical for every claimant. The proposed system assigns points based on factors including a person’s diagnosis and degree of exposure. Two additional funds could provide more money for damages or unusual circumstances that the basic award does not cover.
| Settlement detail | Terms reported |
|---|---|
| Potential total commitment | Up to $7.35 billion |
| Payment period | Nine years |
| Payment in 2026 | $50 million |
| Payment in 2027 | None |
| Present value cited by 3M | $5.8 billion |
Under the agreement, 3M would pay $50 million in 2026 and nothing in 2027. About 20% of the total payments would be made during the final two years. The company also said the arrangement includes a $680 million reserve for remaining and future claims.
“This settlement is a significant milestone for 3M and substantially reduces litigation uncertainty.” — 3M Chairman and CEO William Brown
The agreement resolves allegations that exposure to PFAS in firefighting foam caused the listed illnesses. The court’s Nov. 4 order started the identification process, but the published details do not establish that every claimant will receive a payment or that all claims will have the same value. Eligibility and awards will depend on the settlement terms, including the diagnosis and exposure factors used in the points system.